chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
CHANDLER CA and BLISS EA | In vitro studies with aureomycin. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112230 |
SCHOENBACH EB et al. | The pharmacology and clinical trial of aureomycin; a preliminary report. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112233 |
DOWLING HF and LEPPER MH | Studies on serum concentrations in humans and preliminary observations on the treatment of human infections with aureomycin. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18124198 |
LENNETTE EH et al. | Treatment of Q fever in man with aureomycin. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112238 |
WRIGHT LT and SANDERS M | The treatment of lymphogranuloma venereum and granuloma inguinale in humans with aureomycin. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112237 |
ANIGSTEIN L et al. | Aureomycin, a new antibiotic with antirickettsial properties; its effect on experimental spotted fever and epidemic typhus. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112236 |
WONG SC and COX HR | Action of aureomycin against experimental rickettsial and viral infections. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112235 |
BRALEY AE and SANDERS M | Aureomycin in ocular infections; a study of its spectrum. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112234 |
LITTLE PA | Use of aureomycin on some experimental infections in animals. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112232 |
COLLINS HS et al. | Clinical studies with aureomycin. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18112231 |